NAD+ precursors: mapping the $3.9B longevity ingredient market
NAD is the defining longevity ingredient of the decade. This report breaks down the $3.9B NAD market, the precursor landscape (NMN vs NR), bioavailability formats, and formulation directions for brands entering the category in 2026.
What's inside
NAD+ precursors have moved from niche anti-ageing forums into mainstream supplement aisles, but the science and the regulation are still catching up with the marketing. Inside, we map the $3.9B market, compare NMN and NR on bioavailability and cost, weigh sublingual, liposomal and capsule formats, and set out the formulation decisions that separate credible entrants from the rest in 2026.
Request the report
Fill in your details and we'll email your copy as soon as it's published.
Home
Our story, capacity and what makes Benova Healthcare a one-stop CDMO partner.
Product catalogue
Market-ready formulations across seven formats. Private label or custom.
Our process
Five integrated stages from formulation to delivery, all under one roof.
Quality & certifications
GMP-certified manufacturing, on-site laboratory testing and batch-level traceability.
About us
The team, the facility and the structural advantages behind our work.